Close

Registration is free and only takes a moment. If you have already registered, please log in now.

Create Account
Forgot your password?
Log In
  • Links
  • Publisher Full Text
  • Authors
  • Marshall E
  • MESH
  • Biotechnology
  • Breast Neoplasms
  • DNA
  • Female
  • Genes, BRCA1
  • Genes, BRCA2
  • Genetics, Medical
  • Humans
  • Patents as Topic
  • United States

Unbound MEDLINE

Patents. U.S. appeals court hears gene patent arguments.

Links

  • Publisher Full Text
  • Authors

    Marshall E

    Source

    Science (New York, N.Y.) 337:6092 2012 Jul 20 pg 277-8

    MeSH

    Biotechnology
    Breast Neoplasms
    DNA
    Female
    Genes, BRCA1
    Genes, BRCA2
    Genetics, Medical
    Humans
    Patents as Topic
    United States

    Pub Type(s)

    News

    Language

    eng

    PubMed ID

    22822118

    Related Citations

    • European opposition to exclusive control over predictive breast cancer testing and the inherent implications for U.S. patent law and public policy: a case study of the Myriad Genetics' BRCA patent controversy.
    • [Federal judge and government of the United States against gene patenting].
    • Gene patents in the dock.
    • Ruling on BRCA gene patents could have limited impact.
    • History of a gene patent: tracing the development and application of commercial BRCA testing.
    • US Supreme Court is asked to rule on validity of patents on BRCA1 and BRCA2 genes.
    • Intellectual property. In a flurry of metaphors, justices debate a limit on gene patents.
    • Weighing in on the future of gene patenting.
    More
    unbound logo
    • Home »
    • Contact Us »
    • Help »
    • Privacy / Disclaimer »
    • Terms of Service »
    • Log In »
    • twitter
    • facebook
    © 2000–2013 Unbound Medicine, Inc. All rights reserved